An effective Pseudomonas aeruginosa vaccine may require one or several antigenic components, and so various antigens of P. aeruginosa are identified for use in immunisation. These polypeptides may optionally be used in combination with other nosocomial antigens.
申请公布号
EP2925355(A2)
申请公布日期
2015.10.07
申请号
EP20130798638
申请日期
2013.11.27
申请人
GLAXOSMITHKLINE BIOLOGICALS S.A.;OSPEDALE SAN RAFFAELE S.R.L.
